NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

Montserrat García‐Closas, Nathaniel Rothman, Claudine Samanic et al.|The Lancet|2005

Cited by 631